• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的黏膜菌群——概述。

Mucosal flora in Crohn's disease and ulcerative colitis - an overview.

机构信息

Department of Gastroenterology, Hepatology and Endocrinology, Charite Hospital, Berlin, Germany.

出版信息

J Physiol Pharmacol. 2009 Dec;60 Suppl 6:61-71.

PMID:20224153
Abstract

The intestinal flora harbors varies pathogens. Clostridium perfringens (gas gangrene), Enterococci (endocarditis), Enterobacteriaceae (sepsis), Bacteroides (abscesses) are present in the large intestine of every healthy person in high concentrations. These bacteria are, however, separated from the colonic wall by an impenetrable mucus layer and are tolerated by the host. This separation is disturbed in patients with inflammatory bowel disease (IBD), where bacteria adhere to the mucosa and invade epithelial cells with concomitant inflammatory response. This chronic bowel inflammation can not subside as long as the mucus barrier remains defective. The inflammatory response interferes with the state of tolerance to the intestinal bacteria and leads to characteristic changes in the biostructure of the faecal microbiota. These changes in the biostructure of faecal microbiota are specific for active Crohn's disease and ulcerative colitis (UC) and can be longitudinally monitored. The reason for the defect of the mucus barrier in IBD patients is unclear. Epidemiologic studies indicate a negative role of western lifestyle and foods and document the rise in the incidence of IBD in the industrialized countries during the 20(th) century. In parallel to this, detergents were introduced in households and emulsifiers were increasingly added to food. The cleaning effect of these on the colonic mucus has to be investigated. The present contribution summarizes new data on the biostructure of the intestinal microbiota.

摘要

肠道菌群中存在各种病原体。产气荚膜梭菌(气性坏疽)、肠球菌(心内膜炎)、肠杆菌科(败血症)和拟杆菌(脓肿)在每个健康人的大肠中都以高浓度存在。然而,这些细菌被一层无法穿透的黏液层与结肠壁隔开,并被宿主耐受。在炎症性肠病(IBD)患者中,这种分离被破坏,细菌黏附在黏膜上并侵入上皮细胞,同时伴有炎症反应。只要黏液屏障仍然存在缺陷,这种慢性肠道炎症就不会消退。炎症反应干扰了对肠道细菌的耐受状态,并导致粪便微生物组的生物结构发生特征性变化。粪便微生物组的这种生物结构变化是活动性克罗恩病和溃疡性结肠炎(UC)的特异性变化,可以进行纵向监测。IBD 患者黏液屏障缺陷的原因尚不清楚。流行病学研究表明,西方生活方式和食物起着负面作用,并记录了 20 世纪工业化国家 IBD 发病率的上升。与此平行的是,家用清洁剂被引入家庭,食品中越来越多地添加乳化剂。必须研究这些物质对结肠黏液的清洁效果。本综述总结了肠道微生物群生物结构的新数据。

相似文献

1
Mucosal flora in Crohn's disease and ulcerative colitis - an overview.炎症性肠病中的黏膜菌群——概述。
J Physiol Pharmacol. 2009 Dec;60 Suppl 6:61-71.
2
Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.黏膜屏障、细菌与炎症性肠病:治疗的可能性
Dig Dis. 2014;32(4):475-83. doi: 10.1159/000358156. Epub 2014 Jun 23.
3
Microbiota and mucosal defense in IBD: an update.肠道微生物群与 IBD 的黏膜防御:最新进展。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):963-976. doi: 10.1080/17474124.2019.1671822. Epub 2019 Oct 11.
4
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.炎症性肠病中的黏膜抗体针对肠道细菌。
Gut. 1996 Mar;38(3):365-75. doi: 10.1136/gut.38.3.365.
5
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.炎症性肠病患者黏膜菌群的空间组织与组成
J Clin Microbiol. 2005 Jul;43(7):3380-9. doi: 10.1128/JCM.43.7.3380-3389.2005.
6
The Intestinal Microbiota in Inflammatory Bowel Disease.炎症性肠病中的肠道微生物群
ILAR J. 2015;56(2):192-204. doi: 10.1093/ilar/ilv030.
7
Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.炎症性肠病青少年粪便微生物群的水平分布。
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):20-7. doi: 10.1097/MPG.0b013e31822d53e5.
8
[Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].[克罗恩病、溃疡性结肠炎。当细菌侵袭肠壁时....]
MMW Fortschr Med. 1999 Dec 16;141(51-52):48-51.
9
Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.活动性克罗恩病和溃疡性结肠炎可基于粪便菌群的生物结构进行特异性诊断和监测。
Inflamm Bowel Dis. 2008 Feb;14(2):147-61. doi: 10.1002/ibd.20330.
10
Intestinal microbiota and ulcerative colitis.肠道微生物群与溃疡性结肠炎。
J Infect Chemother. 2015 Nov;21(11):761-8. doi: 10.1016/j.jiac.2015.07.010. Epub 2015 Sep 4.

引用本文的文献

1
Early subclinical stages of the inflammatory bowel diseases: insights from human and animal studies.炎症性肠病的早期亚临床阶段:来自人类和动物研究的见解
Am J Physiol Gastrointest Liver Physiol. 2025 Jan 1;328(1):G17-G31. doi: 10.1152/ajpgi.00252.2024. Epub 2024 Nov 5.
2
The Role of the Gut Microbiome in Inflammatory Bowel Disease: The Middle East Perspective.肠道微生物群在炎症性肠病中的作用:中东视角
J Pers Med. 2024 Jun 18;14(6):652. doi: 10.3390/jpm14060652.
3
Effectiveness of Saccharomyces boulardii CNCM I-745 in Adult Indian Patients with Diarrhoea: A Real-world, Multicentre, Retrospective, Comparative Study.
布拉酵母菌CNCM I-745对成年印度腹泻患者的疗效:一项真实世界、多中心、回顾性、对照研究
Drugs Real World Outcomes. 2024 Jun;11(2):309-316. doi: 10.1007/s40801-024-00424-3. Epub 2024 Apr 6.
4
Rhubarb extract rebuilding the mucus homeostasis and regulating mucin-associated flora to relieve constipation.大黄提取物重建黏液动态平衡并调节黏蛋白相关菌群,以缓解便秘。
Exp Biol Med (Maywood). 2023 Dec;248(23):2449-2463. doi: 10.1177/15353702231211859. Epub 2023 Dec 11.
5
Biofilm's Impact on Inflammatory Bowel Diseases.生物膜对炎症性肠病的影响。
Cureus. 2023 Sep 18;15(9):e45510. doi: 10.7759/cureus.45510. eCollection 2023 Sep.
6
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats.多菌株益生菌通过调节大鼠的微生物群、血清素和短链脂肪酸来缓解洛哌丁胺引起的便秘。
Front Microbiol. 2023 Jun 2;14:1174968. doi: 10.3389/fmicb.2023.1174968. eCollection 2023.
7
Opinion on the re-evaluation of sodium carboxy methyl cellulose (E 466) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as food additive for uses in foods for all population groups.关于重新评估羧甲基纤维素钠(E 466)作为16周龄以下婴儿食品中的食品添加剂以及对其作为所有人群食品添加剂重新评估的后续跟进意见。
EFSA J. 2022 Dec 9;20(12):e07665. doi: 10.2903/j.efsa.2022.7665. eCollection 2022 Dec.
8
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance.炎症性肠病与个性化营养干预:关注肠道微生物组平衡
Nutrients. 2022 Oct 3;14(19):4117. doi: 10.3390/nu14194117.
9
The impact of selected food additives on the gastrointestinal tract in the example of nonspecific inflammatory bowel diseases.以非特异性炎症性肠病为例,某些食品添加剂对胃肠道的影响。
Arch Med Sci. 2021 Jan 8;18(5):1286-1296. doi: 10.5114/aoms/125001. eCollection 2022.
10
IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine.IBD 相关 Atg16L1T300A 多态性调节肠道共生菌群。
Front Immunol. 2022 Jan 27;12:772189. doi: 10.3389/fimmu.2021.772189. eCollection 2021.